Top

Reactions Weekly

Published in:

01-03-2021 | Hepatocellular Carcinoma | Case report

Regorafenib

Jaundice: case report

Published in: Reactions Weekly | Issue 1/2021

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Kawanami GH, et al. How Much Time Should Be Waited and What Are the Main Findings to Evaluate the Hepatocellular Carcinoma Response to Regorafenib? A Real-Life Experience. Canadian Journal of Gastroenterology and Hepatology 2021: 10 Jan 2021. Available from: URL: http://doi.org/10.1155/2021/6219896

Title: Regorafenib
Jaundice: case report
Publication date: 01-03-2021
Publisher: Springer International Publishing
Keywords: Hepatocellular Carcinoma
Hepatocellular Carcinoma
Regorafenib
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-92525-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Regorafenib

Jaundice: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Tobramycin/vancomycin

Carboplatin/etoposide/ifosfamide

Alemtuzumab/immune globulin

Levodopa/carbidopa

Losartan

Olmutinib/osimertinib